MedTrace Logo

Preoperative Immunonutrition in Laparoscopic Total D2 Gastrectomy

NCT05259488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2022-02-28

No results posted yet for this study

Summary

Immunonutrition (IN) appears to reduce infective complications and in-hospital length of stay (LOS) after gastrointestinal surgery. More specifically, it seems to be beneficial also in gastric cancer surgery. Potential benefits of combining preoperative IN (PIN) with protocols of enhanced recovery after surgery (ERAS) in reducing LOS in laparoscopic total gastrectomy are yet to be determined.

Conditions

  • Gastric Cancer
  • Surgery
  • Laparoscopic
  • Gastric Neoplasm
  • Digestive Cancer

Interventions

DIETARY_SUPPLEMENT

immunonutrition

nutridrinks 3 times a day 5 days prior surgery plus maltodextrins the day of surgery

Sponsors & Collaborators

  • University of Rome Tor Vergata

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2021-12-31
Completion
2022-01-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05259488 on ClinicalTrials.gov